Publication | Closed Access
Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score
11
Citations
33
References
2016
Year
LAM reduces the 8-week mortality rate significantly in patients with HBV-related ACLF who had MELD score of at least 24.5.
| Year | Citations | |
|---|---|---|
Page 1
Page 1